Atul Kaushik

Prof. Dr. Atul Kaushik

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2012 in Saudi Journal of Biological Sciences
Verified
Journal Article
Open access
AAAnghesom Ambesajir
Anghesom Ambesajir
AKAtul Kaushik
Atul Kaushik
JKJeevan J. Kaushik
Jeevan J. Kaushik
SPSham T. Petros
Sham T. Petros
RNA interference is a post transcriptional gene silencing mechanism that is triggered by double-stranded RNA (dsRNA). Various attributes of the 3' end structure, including overhang length and sequence composition, plays a primary role in determining the position of the Dicer cleavage in both dsRNA and unimolecular, short hairpin RNA (shRNA). The specificity and robustness of RNAi have triggered an immense interest in using RNAi as a tool in various settings. RNAi is a mechanism for controlling normal gene expression which has recently began to be employed as a potential therapeutic agent for a wide range of disorders, including cancer, infectious diseases and metabolic disorders. Clinical trials with RNAi have now begin, but major obstacles, such as off-target effects, toxicity and unsafe delivery methods, have to be overcome before RNAi can be considered as a conventional drug. It is also used as a tool to improve crops by providing resistance against parasites and modified versions of siRNA that are directed against disease causing genes are being developed, some of which are already tested in clinical trials. In this paper, we first reviewed the RNAi mechanism and then focussed on some of its applications in biomedical research such as treatment for HIV, viral hepatitis and several other diseases.

18 December 2018 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
Nebyu D. AmahaNebyu D. Amaha
Nebyu D. Amaha
YBYohana Haile Berhe
Yohana Haile Berhe
AKAtul Kaushik
Atul Kaushik
Inappropriate use of antibiotics in primary care and hospital settings is a major contributing factor to the spread of antibiotic resistance. Many microorganisms were tested in Eritrea and have proven resistant to ampicillin. The aim of this study was to investigate the prescription pattern, hospital indicator and patient care indicator of antibiotics among hospitalized patients in Halibet National Referral Hospital, Asmara, Eritrea. The data on prescription patterns showed 79% of hospitalizations had at least one antibiotic prescribed and on average 1.29 antibiotics were prescribed per hospitalization; prescribing using generic name was at 97%; all (100%) of the antibiotics were prescribed from the Eritrean National List of Medicines. On average an antibiotic was prescribed for 6.36 days (SD = 6.06). Ampicillin was the most commonly prescribed antibiotic (42.1%) and parenteral was the most common route prescribed (81.4%). The data on hospital indicators showed key antibiotics were out of stock on average for 78.18 days; 87.5% of key antibiotics were available on the day of the study. The data on patient care indicator showed patients taking antibiotics stayed in the hospital for 9.97 days (± 7.33 days).

22 February 2024 in Journal of Parasitic Diseases
Verified
Journal Article
Closed access
PDF file
JKJeevan Jyoti Kaushik
Jeevan Jyoti Kaushik
AKAtul Kaushik
Atul Kaushik
DMDawit Mebrahtu
Dawit Mebrahtu
EBEfrem Bereket
Efrem Bereket
EEElen Eyob
Elen Eyob
RARahwa Andebrhan
Rahwa Andebrhan

16 June 2026 in Scientific Reports
Verified
Journal Article
Open access
PCPragya Chettri
Pragya Chettri
AKAtul Kaushik
Atul Kaushik
PGPradyumna Ghosal
Pradyumna Ghosal
IMIndra Manger
Indra Manger
MHMohammed Elfatih Hamida
Mohammed Elfatih Hamida
JKJeevan Jyoti Kaushik
Jeevan Jyoti Kaushik
Breast cancer remains a major global health challenge, necessitating the exploration of safer and effective plant-derived therapeutics. Thalictrum foliolosum DC. (Pili Jadi), a medicinal herb widely used in Himalayan traditional medicine, is known to contain bioactive alkaloids and phenolic compounds with potential pharmacological properties. The present study investigated the phytochemical composition, antioxidant potential, HPTLC fingerprinting, and In-vitro cytotoxic activity of marketed T. foliolosum root extract against MCF-7 breast cancer cells. Preliminary phytochemical screening revealed the presence of alkaloids, flavonoids, phenolics, tannins, saponins, and terpenoids. The total phenolic content of the ethanolic root extract was determined as 16.80 ± 1.82 mg GAE/g dry weight using the Folin-Ciocalteu assay. Antioxidant activity evaluated by the DPPH radical scavenging assay demonstrated concentration-dependent activity, with the aqueous fraction exhibiting the strongest antioxidant potential (82% radical scavenging activity at 800 µg/mL; IC₅₀ = 313.5 µg/mL), followed by the ethyl acetate fraction. HPTLC fingerprinting confirmed the presence of characteristic phytochemical markers, including quercetin (Rf ≈ 0.51) and berberine (Rf ≈ 0.12). Cytotoxic evaluation using the MTT assay showed a mild dose-dependent reduction in MCF-7 cell viability, with 91.03% viability observed at 100 µg/mL and IC₅₀ > 100 µg/mL. The findings indicate that marketed T. foliolosum roots possess significant antioxidant phytochemicals and identifiable bioactive constituents supporting their traditional therapeutic claims. Further studies involving phytochemical isolation, mechanistic investigations, and in vivo validation are warranted to explore their full anticancer potential.

8 April 2026 in Clinical Nutrition ESPEN
Verified
Journal Article
Open access
Nebyu D. AmahaNebyu D. Amaha
Nebyu D. Amaha
KGKibra Berhe Gidey
Kibra Berhe Gidey
AKAtul Kaushik
Atul Kaushik
Zohra S LassiZohra S Lassi
Zohra S Lassi
EYEngida Yisma
Engida Yisma
Emerging evidence indicates that dietary fibre may influence mental health via mechanisms related to the gut-brain axis. However, population-level evidence examining the association between dietary fibre intake and depressive symptoms before and during the COVID-19 pandemic remains limited. We examined the associations between energy-adjusted and energy-unadjusted dietary fibre intake and depressive symptoms across these two time periods. We analysed data from the National Health and Nutrition Examination Survey (NHANES) conducted before the COVID-19 pandemic (January 2017-March 2020; n = 7,513) and during the pandemic (August 2021-August 2023; n = 4,680). Depressive symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9), with scores ≥10 indicating depression. Dietary fibre intake (g/day) was assessed using a 24-h dietary recall. Energy-adjusted dietary fibre intake was derived using the residual method to account for total energy intake, thereby isolating the effect of fibre independent of total caloric consumption. Associations between energy-adjusted and energy-unadjusted dietary fibre intake and depressive symptoms were estimated using modified Poisson regression models, adjusting for relevant covariates including sociodemographic characteristics. The prevalence of depression increased from 8.0% pre-pandemic to 10.1% during the pandemic. Mean dietary fibre intake decreased from 16.52 g/day pre-pandemic to 15.95 g/day during the pandemic. Each additional 5 g of energy-adjusted fibre intake was associated with a 14% lower prevalence of depressive symptoms before the pandemic (adjusted prevalence ratio (aPR) = 0.86; 95% CI: 0.81, 0.92)), whereas the association was attenuated during the pandemic (aPR = 0.98; 95% CI: 0.91, 1.05). In energy-unadjusted analyses, a 1 g/day increase in fibre intake was associated with a 2% lower depression prevalence (aPR = 0.98; 95% CI: 0.97, 0.99) pre-pandemic but was insignificant (aPR = 0.99; 95% CI: 0.98, 1.00) during the pandemic. Gender-stratified analyses revealed that prior to the pandemic, higher energy-adjusted dietary fibre intake was associated with a lower prevalence of depressive symptoms among men (aPR = 0.79; 95% CI: 0.71, 0.88) and women (aPR = 0.91; 95% CI: 0.84, 0.99). During the pandemic, the association was attenuated among men (aPR = 1.04; 95% CI: 0.92, 1.17), whereas a modest protective association persisted among women (aPR = 0.90; 95% CI: 0.81, 0.99). Higher energy-adjusted dietary fibre intake was associated with lower depressive symptoms before the pandemic in both men and women. During the pandemic, however, the protective association persisted only among women. These findings suggest that dietary fibre may offer continued mental health benefits for women even under societal stressors, highlighting its potential as a gender-specific nutritional target for depression prevention.